World's Best Scientists 2026 revealed!
Silvana Canevari

Silvana Canevari

D-Index & Metrics

Biology and Biochemistry

D-Index
68
Citations
15291
World Ranking
7853
National Ranking
199

Silvana Canevari publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Silvana Canevari sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 340 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Silvana Canevari D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Silvana Canevari sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 68 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Silvana Canevari is affiliated with the University of Milan in Italy. Their research primarily focuses on medical and molecular biology fields, with a particular concentration in oncology. Their scholarly output includes extensive work on cancer research, head and neck cancer studies, and ovarian cancer diagnosis and treatment.

Their main fields of study include Medicine and Biochemistry, Genetics, and Molecular Biology. Within these fields, they have contributed significantly to subfields such as Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Otorhinolaryngology, and Cancer Research.

The primary topics Canevari has worked on encompass:

  • Head and Neck Cancer Studies
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer-related molecular mechanisms research
  • Ovarian cancer diagnosis and treatment
  • Viral-associated cancers and disorders
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cancer Immunotherapy and Biomarkers

Canevari has co-authored multiple publications with frequent collaborators, including Loris De Cecco, Stefano Cavalieri, Lisa Licitra, Mara Serena Serafini, and Deborah Lenoci.

The scientist's frequent publication venues reflect their research focus and include Translational Research, Cells, Frontiers in Oncology, British Journal of Cancer, and Nature Communications.

Recent notable papers by Silvana Canevari include:

  • Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes (2022, British Journal of Cancer)
  • Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial (2023, Nature Communications)
  • Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project (2020, Head & Neck)
  • Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus-Positive Oropharyngeal Carcinoma (2021, JCO Precision Oncology)
  • Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience (2020, Cells)

Best Publications

  • A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

    Michael H. Kershaw;Michael H. Kershaw;Michael H. Kershaw;Jennifer A. Westwood;Jennifer A. Westwood;Linda L. Parker;Gang Wang;Gang Wang

  • Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificity

    S. Miotti;S. Canevari;S. Ménard;D. Mezzanzanica

  • Targeting folate receptor alpha for cancer treatment

    Anthony Cheung;Heather J. Bax;Debra H. Josephs;Kristina M. Ilieva

  • Alterations of Choline Phospholipid Metabolism in Ovarian Tumor Progression

    Egidio Iorio;Delia Mezzanzanica;Paola Alberti;Francesca Spadaro

  • Generation of monoclonal antibodies reacting with normal and cancer cells of human breast.

    Sylvie Mènard;Elda Tagliabue;Silvana Canevari;Giuseppe Fossati

  • Targeting the Folate Receptor: Diagnostic and therapeutic approaches to personalize cancer treatments

    J. A. Ledermann;Silvana Canevari;T. Thigpen

  • Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland

    E G Bremer;S B Levery;S Sonnino;R Ghidoni

  • Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody.

    Silvana Canevari;Gerrit Stoter;Flavio Arienti;Giorgio Bolis

  • Activation of Phosphatidylcholine Cycle Enzymes in Human Epithelial Ovarian Cancer Cells

    Egidio Iorio;Alessandro Ricci;Marina Bagnoli;Maria Elena Pisanu

  • Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer.

    Marina Bagnoli;Silvana Canevari;Delia Mezzanzanica

  • Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19

    L.T. Mantovani;S. Miotti;S. Ménard;S. Canevari

  • Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro.

    V Dolo;S D'Ascenzo;S Violini;L Pompucci

  • Selective Localization of Matrix Metalloproteinase 9, β1 Integrins, and Human Lymphocyte Antigen Class I Molecules on Membrane Vesicles Shed by 8701-BC Breast Carcinoma Cells

    Vincenza Dolo;Angela Ginestra;Donata Cassarà;Stefania Violini

  • Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional Axl receptor kinase

    Marialuisa Sensi;Mara Catani;Giancarlo Castellano;Gabriella Nicolini

  • The involvement of the transcription factor Yin Yang 1 in cancer development and progression

    Giancarlo Castellano;Elena Torrisi;Giovanni Ligresti;Grazia Malaponte

  • Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity

    M. Chinol;P. Casalini;M. Maggiolo;S. Canevari

  • Gene Transfection and Expression of the Ovarian Carcinoma Marker Folate Binding Protein on NIH/3T3 Cells Increases Cell Growth in Vitro and in Vivo

    Federica Bottero;Antonella Tomassetti;Silvana Canevari;Silvia Miotti

  • Targeting of Interleukin 2 to Human Ovarian Carcinoma by Fusion with a Single-Chain Fv of Antifolate Receptor Antibody

    Cecilia Melani;Mariangela Figini;Daniela Nicosia;Elena Luison

  • The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects.

    Lidia Moserle;Stefano Indraccolo;Margherita Ghisi;Chiara Frasson

  • Activation of the Osteopontin/Matrix Metalloproteinase-9 Pathway Correlates with Prostate Cancer Progression

    Giancarlo Castellano;Grazia Malaponte;Maria C. Mazzarino;Mariangela Figini

Frequent Co-Authors

Maria I. Colnaghi
Maria I. Colnaghi University of Milan
Sylvie Ménard
Sylvie Ménard University of Milan
Silvana Pilotti
Silvana Pilotti University of Milan
Lisa Licitra
Lisa Licitra University of Milan
Silvano Ferrini
Silvano Ferrini University of Genoa
Alessandro Ricci
Alessandro Ricci University of Bologna
Marco A. Pierotti
Marco A. Pierotti University of Bari Aldo Moro
Massimo Libra
Massimo Libra University of Catania
Elda Tagliabue
Elda Tagliabue Fondazione IRCCS Istituto Nazionale dei Tumori
Maria Grazia Daidone
Maria Grazia Daidone University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Silvana Canevari

Trending Scientists

Recently Published Articles